Startups
2024
NEMA HEALTH SLInnovative personalized therapies for the treatment of cancer in humans and other animal species.
Nema Health’s technology is based on the therapeutic effect induced by the patient neoantigens extracted from the tumor when formulated /adjuvanted with a set of proprietary peptides known as DIF peptides
Nema Health’s technology is based on the therapeutic effect induced by the patient neoantigens extracted from the tumor when formulated /adjuvanted with a set of proprietary peptides known as DIF peptides
Address
Lugar Parc Gardeny 0, 25003 Lleida, Spain
CERCA ownership
Barcelona, Spain
2002
Vall d’Hebron Institut de Recerca (VHIR)
Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
NEMA Health technology makes the tumor visible for the immune system, which attack and destroy the tumor cells.
Product description
Nema Health treatment is being developed for the treatment of malignant melanoma. However, many other cancers are potential candidates for its use, including some that currently have no effective treatment, such as lung, pancreatic or ovarian cancers. Furthermore, Nema Health's treatment is not only useful for the treatment of cancer in humans but also has enormous potential as a veterinary treatment